Mitchel L. Zoler, PhD

Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler

Article

Vedolizumab shows safety, efficacy for pediatric IBD

Author:: Mitchel L. Zoler, PhD

Publish date: October 19, 2016

MONTREAL – Treatment with vedolizumab was safe and effective for pediatric patients with inflammatory bowel disease.

Article

CD64 validated as biomarker for pediatric Crohn’s disease

Author:: Mitchel L. Zoler, PhD

Publish date: October 18, 2016

Results from two studies further validated neutrophil CD64 as a highly specific biomarker for Crohn’s disease severity in children and adoles...

Article

Palliative care boosts heart failure patient outcomes

Author:: Mitchel L. Zoler, PhD

Publish date: October 16, 2016

Adding palliative care interventions to management of patients with advanced heart failure improved quality-of-life measures in two relatively smal...

Article

Cow’s milk allergy appears to affect more U.S. infants than thought

Author:: Mitchel L. Zoler, PhD

Publish date: October 12, 2016

Cow’s milk protein allergy may occur more often among U.S. infants than the pediatric literature suggests.

Article

VIDEO: Harvoni shows safety, efficacy in adolescents for hepatitis C

Author:: Mitchel L. Zoler, PhD

Publish date: October 11, 2016

One of the antiviral drug combinations that has revolutionized treatment of hepatitis C virus in adults has for the first time been shown safe and ...

Article

FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF

Author:: Mitchel L. Zoler, PhD

Publish date: October 11, 2016

The Food and Drug Administration reaffirmed its confidence in the data supporting the claim that rivaroxaban (Xarelto) is a safe and effective alte...

Article

October 2016: Click for Credit

Author:: Mitchel L. Zoler, PhD

Publish date: October 1, 2016

Topics include: Autism follow-up screening • Gallstone disease and heart risk • HER2-testing guidelines • Weight loss and T...

News

Reimbursement hurdles hinder Entresto use in HFrEF

Author:: Mitchel L. Zoler, PhD

Publish date: September 28, 2016

News

NOACs outpace warfarin for afib anticoagulation

Author:: Mitchel L. Zoler, PhD

Publish date: September 21, 2016

News

CardioMEMS shows real-world heart failure benefit

Author:: Mitchel L. Zoler, PhD

Publish date: September 21, 2016

Key clinical point: Registry data from the first 2,000 U.S.

News

ESC’s new lipid guidelines keep LDL-cholesterol targets

Author:: Mitchel L. Zoler, PhD

Publish date: September 20, 2016

News

More TOPCAT flaws back spironolactone’s HFpEF efficacy

Author:: Mitchel L. Zoler, PhD

Publish date: September 19, 2016

Key clinical point: A post hoc analysis of spironolactone use among TOPCAT participants further fueled the idea that spironolactone provides real ...

News

Trials offer lessons despite negative primary endpoints

Author:: Mitchel L. Zoler, PhD

Publish date: September 9, 2016

Video

VIDEO: Coronary DES outperform BMS mostly on restenosis

Author:: Mitchel L. Zoler, PhD

Publish date: September 1, 2016

Key clinical point: The benefit from coronary revascularization with drug-eluting stents, compared with bare-metal stents, was mostly in a reduced ...

Video

VIDEO: Functional noninvasive imaging cuts unnecessary angiography

Author:: Mitchel L. Zoler, PhD

Publish date: August 30, 2016

Key clinical point: Screening patients with suspected angina via cardiovascular MR or myocardial perfusion imaging substantially reduced the rate o...